When will the world get cancer vaccines?
Vaccines against cancer have been a dream for decades, but the mRNA revolution has sparked new hope. Chris Baraniuk looks at what’s in the pipeline—and the challenges that remain On 6 January 2023 the UK government announced that it was partnering with BioNTech, the company that created the first covid-19 mRNA vaccine, to enrol as many as 10 000 patients in trials of a new mRNA cancer vaccine.1 Iain Foulkes, speaking for Cancer Research UK, told BBC News that “mRNA vaccines are one of the most exciting research developments to come out of the pandemic, and there are strong hints that they could become powerful treatment options for cancer.” For BioNTech, it’s a huge step forward considering the company was founded nearly 15 years ago to develop mRNA therapies for cancer. Cancer kills considerably more people worldwide each year than covid-19 does, according to World Health Organization figures. Countless companies and research institutions around the world have long targeted cancer vac